# mAbxience agrees to produce AstraZeneca COVID-19 vaccine in Argentina

mAbxience entered into an agreement with AstraZeneca to produce the COVID-19 vaccine at its Garín plant in Argentina. The active ingredient will be sent to Mexico for filling, with over 200 million doses supplied to Latin America.

- Type: Contract
- Announced: 2019-08-17
- Where: Garín, Argentina, Argentina
- Status: announced
- Products: COVID-19 vaccine
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [mAbxience](https://endata.com/companies/41412.md)
- [AstraZeneca](https://endata.com/companies/35467.md) (customer)

## Sources

- [chemopharmaceuticals.com](https://www.chemopharmaceuticals.com/en/new/1077/), 2019-08-17: "mAbxience, the biotec company of the Spanish Insud Pharma group, is deeply proud to announce that has entered into an agreement with AstraZeneca to produce a Covid-19 vaccine in Latin America."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.